Google A.I. System Wins Gold Medal in International Math Olympiad
It was the first time a machine — which solved five of the six problems at the 2025 competition, held in Australia this month — reached that level of success, Google said in a blog post on Monday.
The news is another sign that leading companies are continuing to improve their A.I. systems in areas like math, science and computer coding. This kind of technology could accelerate the research of mathematicians and scientists and streamline the work of experienced computer programmers.
Two days before Google revealed its feat, an OpenAI researcher said in a social media post that the start-up had built technology that achieved a similar score on this year's questions, though it did not officially enter the competition.
Both systems were chatbots that received and responded to the questions much like humans. Other A.I. systems have participated in the International Mathematical Olympiad, or I.M.O., but they could answer questions only after human experts translated them into a computer programming language built for solving math problems.
'We solved these problems fully in natural language,' Thang Luong, a senior staff research scientist at Google DeepMind, said in an interview. 'That means there was no human intervention — at all.'
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Millions of people are suffering from brain fog. A new study will find out why
Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise. Medically the symptoms are known as myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). The World Health Organization classifies this as a post viral fatigue syndrome, and it is recognised by both the WHO and the United States Centers for Disease Control and Prevention as a brain disorder. Experiencing illness long after contracting an infection is not new, as patients have reported these symptoms for decades. But COVID-19 has amplified the problem worldwide. Nearly half of people with ongoing post-COVID symptoms – a condition known as long-COVID – now meet the criteria for ME/CFS. Since the start of the pandemic in 2020, it is estimated that more than 400 million people have developed long-COVID. To date, no widely accepted and testable mechanism has fully explained the biological processes underlying long-COVID and ME/CFS. Our work offers a new perspective that may help close this gap. Our research group studies blood and the cardiovascular system in inflammatory diseases, as well as post-viral conditions. We focus on coagulation, inflammation and endothelial cells. Endothelial cells make up the inner layer of blood vessels and serve many important functions, like regulating blood clotting, blood vessel dilation and constriction, and inflammation. Our latest review aims to explain how ME/CFS and long-COVID start and progress, and how symptoms show up in the body and its systems. By pinpointing and explaining the underlying disease mechanisms, we can pave the way for better clinical tools to diagnose and treat people living with ME/CFS and long-COVID. What is endothelial senescence? In our review, our international team proposes that certain viruses drive endothelial cells into a half-alive, 'zombie-like' state called cellular senescence. Senescent endothelial cells stop dividing, but continue to release molecules that awaken and confuse the immune system. This prompts the blood to form clots and, at the same time, prevent clot breakdown, which could lead to the constriction of blood vessels and limited blood flow. By placing 'zombie' blood-vessel cells at the centre of these post-viral diseases, our hypothesis weaves together microclots, oxygen debt (the extra oxygen your body needs after strenuous exercise to restore balance), brain-fog, dizziness, gut leakiness (a digestive condition where the intestinal lining allows toxins into the bloodstream) and immune dysfunction into a single, testable narrative. From acute viral infection to 'zombie' vessels Viruses like SARS-CoV-2, Epstein–Barr virus, HHV-6, influenza A, and enteroviruses (a group of viruses that cause a number of infectious illnesses which are usually mild) can all infect endothelial cells. They enable a direct attack on the cells that line the inside of blood vessels. Some of these viruses have been shown to trigger endothelial senescence. Multiple studies show that SARS-CoV-2 (the virus which causes COVID-19 disease) has the ability to induce senescence in a variety of cell types, including endothelial cells. Viral proteins from SARS-CoV-2, for example, sabotage DNA-repair pathways and push the host cell towards a senescent state, while senescent cells in turn become even more susceptible to viral entry. This reciprocity helps explain why different pathogens can result in the same chronic illness. Influenza A, too, has shown the ability to drive endothelial cells into a senescent, zombie-like state. What we think is happening We propose that when blood-vessel cells turn into 'zombies', they pump out substances that make blood thicker and prone to forming tiny clots. These clots slow down circulation, so less oxygen reaches muscles and organs. This is one reason people feel drained. During exercise, the problem worsens. Instead of the vessels relaxing to allow adequate bloodflow, they tighten further. This means that muscles are starved of oxygen and patients experience a crash the day after exercise. In the brain, the same faulty cells let blood flow drop and leak, bringing on brain fog and dizziness. In the gut, they weaken the lining, allowing bits of bacteria to slip into the bloodstream and trigger more inflammation. Because blood vessels reach every corner of the body, even scattered patches of these 'zombie' cells found in the blood vessels can create the mix of symptoms seen in long-COVID and ME/CFS. Immune exhaustion locks in the damage Some parts of the immune system kill senescent cells. They are natural-killer cells, macrophages and complement proteins, which are immune molecules capable of tagging and killing pathogens. But long-COVID and ME/CFS frequently have impaired natural-killer cell function, sluggish macrophages and complement dysfunction. Senescent endothelial cells may also send out a chemical signal to repel immune attack. So the 'zombie cells' actively evade the immune system. This creates a self-sustaining loop of vascular and immune dysfunction, where senescent endothelial cells persist. In a healthy person with an optimally functioning immune system, these senescent endothelial cells will normally be cleared. But there is significant immune dysfunction in ME/CFS and long-COVID, and this may enable the 'zombie cells' to survive and the disease to progress. Where the research goes next There is a registered clinical trial in the US that is investigating senescence in long-COVID. Our consortium is testing new ways to spot signs of ageing in the cells that line our blood vessels. First, we expose healthy endothelial cells in the lab to blood from patients to see whether it pushes the cells into a senescent, or 'zombie,' state. At the same time, we are trialling non‑invasive imaging and fluorescent probes that could one day reveal these ageing cells inside the body. In selected cases, tissue biopsies may later confirm what the scans show. Together, these approaches aim to pinpoint how substances circulating in the blood drive cellular ageing and how that, in turn, fuels disease. Our aim is simple: find these ageing endothelial cells in real patients. Pinpointing them will inform the next round of clinical trials and open the door to therapies that target senescent cells directly, offering a route to healthier blood vessels and, ultimately, lighter disease loads. Burtram C. Fielding is Dean Faculty of Sciences and Professor in the Department of Microbiology, Stellenbosch University This article is republished from The Conversation under a Creative Commons license. Read the original article.
Yahoo
33 minutes ago
- Yahoo
You Can Try Google's New 'Vibe Coding' App For Free Right Now
Google has been working to improve its AI coding capabilities alongside other AI companies like OpenAI and Anthropic. Many believe that AI can improve coding workflows, and it has proven time and time again that it can make the job more efficient and easier. Some have even taken to 'vibe coding,' which is the act of basically letting AI do all of the work and then just ensuring it works before you implement it. Vibe coding, many argue, is the lazy way out. Others have seen it as a way to open up the world of coding to people who might otherwise struggle to put out the code they're trying to make. And Google has been leaning into this a bit already, with the debut of Jules, an AI coding agent, earlier this year. But now Google is looking to go a step further. Instead of just helping you improve on your own code, as Jules is designed to do, a new agent called Opal will help you dive deep into vibe coding. And if you're interested in trying it, then you can sign up for Google Labs and try out Opal for yourself today for free. An AI Agent Designed To Build Apps With Natural Language Google says that Opal is designed to build, edit, and share mini-AP apps using natural language. This means you should be able to tell the AI exactly what you want -- by saying something like "make an app to order breakfast" -- and then it will spit out a project that you can tweak and change fairly effortlessly. Opal also makes it easy to share your apps, allowing you to package them and show them off with minimal effort. Of course, vibe coding is a novel idea that could open the door for new coding opportunities. But it could also turn out really poorly if you don't know what you're doing. While vibe coding has garnered a lot of praise and interest, it also has its risks. Recently, a venture capitalist shared details about an ongoing project he'd been working on using Replit, an AI designed to help with vibe coding. Despite putting hours of work into the project, the AI deleted his entire database simply because it "panicked." Despite these downsides, it's hard to argue with how easy vibe coding makes projects, and having more accessible apps like Opal will only lead to more improvements across the board. You just have to decide if the ease of use is worth it, or if you're one of the many who believe innovations like this could make it easier for AI to overtake humanity. Read the original article on BGR.
Yahoo
2 hours ago
- Yahoo
Cisco Systems (CSCO): A Steady Performer Among the Dogs of the Dow
Cisco Systems, Inc. (NASDAQ:CSCO) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A technician in a laboratory, overseeing cutting edge cybersecurity solutions. Cisco Systems, Inc. (NASDAQ:CSCO) is widely recognized for its networking, cybersecurity, software, and cloud computing solutions. It produces routers and switches that use the Internet Protocol to move data across networks. Artificial intelligence has become a major growth area for Cisco Systems, Inc. (NASDAQ:CSCO), with AI-related revenue exceeding $1 billion in 2024. Cisco aims to at least double that figure in 2025. A key factor in this expansion has been its $28 billion acquisition of Splunk, completed last year, which is intended to strengthen customers' capabilities in networking, security, and AI. Cisco Systems, Inc. (NASDAQ:CSCO) reported strong earnings in its fiscal Q3 2025. The company's revenue came in at $14.15 billion, which showed an 11.4% growth from the same period last year. The revenue also beat analysts' estimates by $91.4 million. Orders for AI infrastructure from webscale clients surpassed $600 million, allowing the company to hit its $1 billion goal a quarter ahead of schedule. This strong performance in AI is driven by the strength of its secure networking solutions, strong global alliances, and the value it consistently delivers to customers. Cisco Systems, Inc. (NASDAQ:CSCO) generated an operating cash flow of $4.1 billion during the quarter, and it returned $1.6 billion to investors through dividends. In addition, it has raised its payouts for 18 consecutive years. Currently, it offers a quarterly dividend of $0.41 per share and has a dividend yield of 2.39%, as of July 26. While we acknowledge the potential of CSCO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
